Fluocinonide and Hair loss - a phase IV clinical study of FDA data
Hair loss is found among people who take Fluocinonide, especially for people who are female, 60+ old, have been taking the drug for < 1 month.
The phase IV clinical study analyzes which people take Fluocinonide and have Hair loss. It is created by eHealthMe based on reports of 4,779 people who have side effects when taking Fluocinonide from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
4,779 people reported to have side effects when taking Fluocinonide.
Among them, 95 people (1.99%) have Hair loss.
What is Fluocinonide?
Fluocinonide has active ingredients of fluocinonide. It is often used in eczema. eHealthMe is studying from 4,817 Fluocinonide users for its effectiveness, alternative drugs and more.
What is Hair loss?
Hair loss is found to be associated with 3,889 drugs and 3,359 conditions by eHealthMe.
Number of Fluocinonide and Hair loss reports submitted per year:
Time on Fluocinonide when people have Hair loss *:
- < 1 month: 80 %
- 1 - 6 months: 10 %
- 6 - 12 months: 0.0 %
- 1 - 2 years: 0.0 %
- 2 - 5 years: 0.0 %
- 5 - 10 years: 10 %
- 10+ years: 0.0 %
Gender of people who have Hair loss when taking Fluocinonide *:
- female: 92.13 %
- male: 7.87 %
Age of people who have Hair loss when taking Fluocinonide *:
- 0-1: 0.0 %
- 2-9: 0.0 %
- 10-19: 0.0 %
- 20-29: 1.43 %
- 30-39: 5.71 %
- 40-49: 15.71 %
- 50-59: 28.57 %
- 60+: 48.57 %
Common drugs people take besides Fluocinonide *:
- Calcium: 12 people, 12.63%
- Biotin: 11 people, 11.58%
- Celebrex: 10 people, 10.53%
- Tecfidera: 10 people, 10.53%
- Vitamin D: 10 people, 10.53%
- Taxotere: 9 people, 9.47%
- Triamcinolone: 9 people, 9.47%
- Metformin: 8 people, 8.42%
- Xanax: 7 people, 7.37%
- Synthroid: 6 people, 6.32%
Common side effects people have besides Hair loss *:
- Muscle Spasms (muscle contraction): 17 people, 17.89%
- Fall: 17 people, 17.89%
- Itching: 15 people, 15.79%
- Fatigue (feeling of tiredness): 14 people, 14.74%
- Hair Texture Abnormal: 14 people, 14.74%
- Rashes (redness): 14 people, 14.74%
- Memory Loss: 14 people, 14.74%
- Rash Erythematous (redness of the skin): 13 people, 13.68%
- Head Injury: 13 people, 13.68%
- Constipation: 12 people, 12.63%
Common conditions people have *:
- Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 11 people, 11.58%
- Breast Cancer Female: 8 people, 8.42%
- Itching: 6 people, 6.32%
- Depression: 6 people, 6.32%
- High Blood Pressure: 5 people, 5.26%
- High Blood Cholesterol: 5 people, 5.26%
- Chronic Myeloid Leukaemia (long lasting type of cancer that starts in the blood-forming cells of the bone marrow and invades the blood): 5 people, 5.26%
- Seborrhoeic Dermatitis (a common, inflammatory skin condition that causes flaky, white to yellowish scales to form on oily areas such as the scalp): 4 people, 4.21%
- Dermatitis Atopic (inflammatory, chronically relapsing, non-contagious and pruritic skin disorder): 4 people, 4.21%
- Sleep Disorder: 4 people, 4.21%
* Approximation only. Some reports may have incomplete information.
Do you take Fluocinonide and have Hair loss?Check whether Hair loss is associated with a drug or a condition
How to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
Related publications that referenced our studies
- Lindsey SF, Tosti A, "Hair loss induced by tumor necrosis factor alpha inhibitors", J Clin Investigat Dermatol, 2015 Jan .
How severe was Hair loss and when was it recovered:
Expand to all the drugs that have ingredients of fluocinonide:
- Hair loss and drugs with ingredients of fluocinonide (50 reports)
Alternative drugs to, pros and cons of Fluocinonide:
- Fluocinonide (4,817 reports)
Common Fluocinonide side effects:
- Rashes (redness): 491 reports
- Drug ineffective: 372 reports
- Itching: 298 reports
- Fatigue (feeling of tiredness): 294 reports
- Diarrhea: 275 reports
- Psoriasis (immune-mediated disease that affects the skin): 264 reports
- Pain: 249 reports
- Headache (pain in head): 239 reports
- Stress and anxiety: 221 reports
- Chronic kidney disease: 201 reports
Browse all side effects of Fluocinonide:a b c d e f g h i j k l m n o p q r s t u v w x y z
Hair loss treatments and more:
- Hair loss (238,701 reports)
COVID vaccines that are related to Hair loss:
- Hair loss in Moderna COVID Vaccine
- Hair loss in Pfizer BioNTech Covid Vaccine
- Hair loss in Johnson and Johnson Covid Vaccine
Common drugs associated with Hair loss:
- Taxotere: 34,064 reports
- Docetaxel: 25,062 reports
- Methotrexate: 16,710 reports
- Humira: 14,833 reports
- Enbrel: 14,300 reports
- Prednisone: 13,908 reports
- Neosar: 11,976 reports
- Remicade: 10,226 reports
- Orencia: 9,671 reports
- Arava: 8,730 reports
All the drugs that are associated with Hair loss:
- Hair loss (3,889 drugs)
Common conditions associated with Hair loss:
- Rheumatoid arthritis: 18,564 reports
- Multiple sclerosis: 13,366 reports
- Breast cancer: 11,002 reports
- Chemotherapy: 8,910 reports
- High blood pressure: 5,484 reports
All the conditions that are associated with Hair loss:
- Hair loss (3,359 conditions)
How the study uses the data?
The study uses data from the FDA. It is based on fluocinonide (the active ingredients of Fluocinonide) and Fluocinonide (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Atrovent Hfa and Blindness - 2 seconds ago
- Weight Loss in Betadine, how severe and when it was recovered? - 2 seconds ago
- Percocet vs. Vivitrol - 3 seconds ago
- Hygroton and Hypophagia - 14 seconds ago
- Fenofibrate and Kadian drug interaction - 16 seconds ago
- Ranolazine and Diazepam drug interaction - 27 seconds ago
- Zovirax and Liver Transplant - 28 seconds ago
- Plavix and Herniated Nucleus Pulposus (Slipped Disk) - 37 seconds ago
- How effective is Tresiba for Type 1 Diabetes? - 38 seconds ago
- Janumet and Dulera drug interaction - 40 seconds ago